**Chapter 3**

*Advances in the Molecular Understanding of Colorectal Cancer*

[69] Kato MV. A secreted tumorsuppressor, mac25, with activinbinding activity. Molecular Medicine.

[70] Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescencelike mechanism. Cell Growth & Differentiation. 2002;**5**:205-213

[71] Adachi Y, Itoh F, Yamamoto H, Arimura Y, Kikkawa-Okabe Y, Miyazaki K, et al. Expression of

of Cancer. 2001;**4**:216-222

10.1007/s10552-013-0318-6

discussion 1811

pone.0090916

angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. International Journal

[72] Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, et al. Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. The Annals of Thoracic Surgery. 2011;**5**:1805-1811. DOI: 10.1016/j.athoracsur.2011.06.058.

[73] Ochs-Balcom HM, Vaughn CB, Nie J, Chen Z, Thompson CL, Parekh N, et al. Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk. Cancer Causes & Control. 2014;**2**:161-170. DOI:

[74] Ong J, Salomon J, te Morsche RH, Roelofs HM, Witteman BJ, Dura P, et al. Polymorphisms in the insulin-like growth factor axis are associated with gastrointestinal cancer. PLoS One. 2014;**3**:e90916. DOI: 10.1371/journal.

2000;**2**:126-135

**34**
